article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. 2005: Liraglutide, another GLP-1 RA, joins the scene, offering longer-lasting action. Subscribe Today! Subscribe Today!

article thumbnail

Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers

Healthcare IT Today

About Phreesia Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies, and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022–more than 1 in 10 visits across the U.S.–a